Skip to main content
Clinical Trials/ISRCTN11348079
ISRCTN11348079
Completed
未知

A multi-centre, randomised controlled trial assessing the effectiveness of Lugol's Iodine in Surgical managemenT of Epithelial dysplasia in the oRal cavity and oropharynx

HS Greater Glasgow and Clyde0 sites40 target enrollmentApril 1, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Epithelial dysplasia in the oral cavity and oropharynx
Sponsor
HS Greater Glasgow and Clyde
Enrollment
40
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2016
End Date
June 1, 2019
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
HS Greater Glasgow and Clyde

Eligibility Criteria

Inclusion Criteria

  • 1\. Provision of written informed consent
  • 2\. Age\= 18 years old
  • 3\. Epithelial dysplasia of the oral cavity or oropharynx, undergoing primary surgical excision under general anaesthesia

Exclusion Criteria

  • 1\. Previous surgery or radiotherapy for head and neck cancer
  • 2\. Allergy to iodine
  • 3\. Previous diagnosis of head \& Neck SCC in the past 5 years or active malignancy within 2 years of randomisation (except basal cell carcinoma or carcinoma of the cervix in\-situ)

Outcomes

Primary Outcomes

Not specified

Similar Trials